R-Pharm Overseas

R-Pharm is a vertically integrated pharmaceutical company that focuses on the research, development, manufacturing, and commercialization of a wide range of therapeutic products. The company operates across several high-tech segments, including specialty care, oncology, hematology, and infectious diseases. R-Pharm is well-known for its extensive manufacturing capabilities and its role as a major partner for international pharmaceutical companies seeking to enter the Russian and CIS markets. Its portfolio includes both innovative proprietary drugs, such as the IL-6 inhibitor Olokizumab, and licensed products through strategic global partnerships. The company maintains a significant international presence through its R-Pharm Overseas division, which manages global clinical trials and business development.